Kenneth K. Wang

20.1k total citations · 2 hit papers
339 papers, 10.8k citations indexed

About

Kenneth K. Wang is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Gastroenterology. According to data from OpenAlex, Kenneth K. Wang has authored 339 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 276 papers in Surgery, 205 papers in Pulmonary and Respiratory Medicine and 68 papers in Gastroenterology. Recurrent topics in Kenneth K. Wang's work include Esophageal Cancer Research and Treatment (223 papers), Gastric Cancer Management and Outcomes (155 papers) and Esophageal and GI Pathology (132 papers). Kenneth K. Wang is often cited by papers focused on Esophageal Cancer Research and Treatment (223 papers), Gastric Cancer Management and Outcomes (155 papers) and Esophageal and GI Pathology (132 papers). Kenneth K. Wang collaborates with scholars based in United States, United Kingdom and Netherlands. Kenneth K. Wang's co-authors include Richard E. Sampliner, Lori S. Lutzke, Navtej Buttar, Ganapathy A. Prasad, Prasad G. Iyer, Charles J. Lightdale, Marlys Anderson, David A. Katzka, Cadman L. Leggett and Lynn S. Borkenhagen and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Kenneth K. Wang

324 papers receiving 10.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus

2008 991 citations Kenneth K. Wang et al. The American Journal of Gastroenterology profile →
Esophagitis Associated with the Use of Alendronate

1996 586 citations Kenneth K. Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kenneth K. Wang United States	53	8.2k	6.1k	2.1k	1.6k	1.1k	339	10.8k
Hironobu Minami Japan	45	2.2k 0.3×	1.7k 0.3×	1.2k 0.6×	4.5k 2.8×	2.7k 2.5×	366	9.2k
Manabu Muto Japan	54	7.4k 0.9×	7.4k 1.2×	1.1k 0.5×	2.7k 1.7×	1.5k 1.4×	362	11.9k
Sung Hoon Noh South Korea	62	6.0k 0.7×	10.8k 1.8×	5.3k 2.5×	3.8k 2.4×	1.7k 1.6×	453	14.9k
Hitoshi Katai Japan	59	4.9k 0.6×	9.0k 1.5×	4.5k 2.1×	2.4k 1.5×	1.5k 1.4×	277	11.8k
Hiroya Takeuchi Japan	49	5.1k 0.6×	5.1k 0.8×	1.1k 0.5×	2.8k 1.8×	1.3k 1.3×	402	9.6k
Il Ju Choi South Korea	51	4.8k 0.6×	6.0k 1.0×	2.8k 1.3×	1.8k 1.1×	1.5k 1.4×	285	9.7k
Hisahiro Matsubara Japan	55	5.5k 0.7×	4.8k 0.8×	512 0.2×	2.7k 1.7×	3.5k 3.3×	506	12.0k
Chun‐Nan Yeh Taiwan	41	2.7k 0.3×	2.2k 0.4×	929 0.4×	1.7k 1.1×	880 0.8×	280	5.5k
Takao Itoi Japan	67	12.2k 1.5×	10.6k 1.7×	1.1k 0.5×	9.1k 5.8×	1.5k 1.5×	626	17.6k
Irene Floriani Italy	47	1.8k 0.2×	2.3k 0.4×	400 0.2×	3.3k 2.1×	1.2k 1.1×	159	8.3k

Countries citing papers authored by Kenneth K. Wang

Since Specialization

Citations

This map shows the geographic impact of Kenneth K. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth K. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth K. Wang more than expected).

Fields of papers citing papers by Kenneth K. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth K. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth K. Wang. The network helps show where Kenneth K. Wang may publish in the future.

Co-authorship network of co-authors of Kenneth K. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth K. Wang. A scholar is included among the top collaborators of Kenneth K. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth K. Wang. Kenneth K. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kamboj, Amrit K., Rohit Goyal, Kornpong Vantanasiri, et al.. (2023). Clinical Outcomes After Endoscopic Management of Low-Risk and High-Risk T1a Esophageal Adenocarcinoma: A Multicenter Study. The American Journal of Gastroenterology. 119(4). 662–670. 8 indexed citations

Bao, Chunyang, Richard W. Tourdot, Gregory J. Brunette, et al.. (2023). Genomic signatures of past and present chromosomal instability in Barrett’s esophagus and early esophageal adenocarcinoma. Nature Communications. 14(1). 6203–6203. 14 indexed citations

Park, Hyeon‐Cheol, Amrit K. Kamboj, Cadman L. Leggett, et al.. (2022). Comparative Study of Conventional and Ultrahigh-resolution Optical Coherence Tomography Imaging in Esophageal Neoplasia. Techniques and Innovations in Gastrointestinal Endoscopy. 24(3). 312–313. 1 indexed citations

Codipilly, Don C. & Kenneth K. Wang. (2022). Squamous Cell Carcinoma of the Esophagus. Gastroenterology Clinics of North America. 51(3). 457–484. 42 indexed citations

Sawas, Tarek, Sarah Killcoyne, Kenneth K. Wang, et al.. (2021). Limitations of Heartburn and Other Societies’ Criteria in Barrett’s Screening for Detecting De Novo Esophageal Adenocarcinoma. Clinical Gastroenterology and Hepatology. 20(8). 1709–1718. 20 indexed citations

Lee, Hee Eun, et al.. (2019). Endoscopic findings of esophageal submucosal gland duct adenoma. VideoGIE. 4(8). 361–363.

Sawas, Tarek, Yuri Hanada, Kavel Visrodia, et al.. (2019). Safety and histologic outcomes of endoscopic submucosal dissection with a novel articulating knife for esophageal neoplasia. Gastrointestinal Endoscopy. 91(4). 797–805. 7 indexed citations

Visrodia, Kavel, Liam Zakko, & Kenneth K. Wang. (2017). Radiofrequency Ablation of Barrett’s Esophagus. Gastrointestinal Endoscopy Clinics of North America. 27(3). 491–501. 5 indexed citations

Prasad, Ganapathy A., Lori S. Lutzke, Kelly T. Dunagan, et al.. (2014). The Risk of Endoscopic Mucosal Resection in the Setting of Clopidogrel Use. PubMed. 2014. 1–5. 7 indexed citations

10.

Leggett, Cadman L., E. Marlo Nelsen, Jianmin Tian, et al.. (2013). Metabolic Syndrome as a Risk Factor for Barrett Esophagus: A Population-Based Case-Control Study. Mayo Clinic Proceedings. 88(2). 157–165. 36 indexed citations

11.

Beuers, Ulrich, Paul Fockens, Cyriel Y. Ponsioen, et al.. (2013). Genetic and Epigenetic Abnormalities in Primary Sclerosing Cholangitis-associated Cholangiocarcinoma. Inflammatory Bowel Diseases. 19(8). 1789–1797. 17 indexed citations

12.

Gu, Jian, Jaffer A. Ajani, Ernest T. Hawk, et al.. (2010). Genome-Wide Catalogue of Chromosomal Aberrations in Barrett's Esophagus and Esophageal Adenocarcinoma: A High-Density Single Nucleotide Polymorphism Array Analysis. Cancer Prevention Research. 3(9). 1176–1186. 67 indexed citations

13.

Kim, Soo Mi, Eun Sung Park, Y. Choi, et al.. (2010). Prognostic Biomarkers for Esophageal Adenocarcinoma Identified by Analysis of Tumor Transcriptome. PLoS ONE. 5(11). e15074–e15074. 115 indexed citations

14.

Yang, Hushan, Jian Gu, Kenneth K. Wang, et al.. (2009). MicroRNA Expression Signatures in Barrett's Esophagus and Esophageal Adenocarcinoma. Clinical Cancer Research. 15(18). 5744–5752. 109 indexed citations

15.

Yen, Chia-Jui, Julie Izzo, Dung‐Fang Lee, et al.. (2008). Bile Acid Exposure Up-regulates Tuberous Sclerosis Complex 1/Mammalian Target of Rapamycin Pathway in Barrett's-Associated Esophageal Adenocarcinoma. Cancer Research. 68(8). 2632–2640. 49 indexed citations

16.

Prasad, Ganapathy A., Kenneth K. Wang, Kevin C. Halling, et al.. (2008). Utility of Biomarkers in Prediction of Response to Ablative Therapy in Barrett's Esophagus. Gastroenterology. 135(2). 370–379. 51 indexed citations

17.

Bronner, Mary P., Bergein F. Overholt, Shari L. Taylor, et al.. (2008). Squamous Overgrowth Is Not a Safety Concern for Photodynamic Therapy for Barrett's Esophagus With High-Grade Dysplasia. Gastroenterology. 136(1). 56–64. 44 indexed citations

18.

Buttar, Navtej, Marlys Anderson, Krishnawatie K. Krishnadath, et al.. (2000). Chemopreventive potential of selective cyclooxygenase-2 (COX-2) inhibition in Barrett's epithelium: An in vitro study. Gastroenterology. 118(4). A35–A35. 6 indexed citations

19.

Nelson, Douglas B., John J. Bosco, Douglas O. Faigel, et al.. (1999). Technology Status Evaluation Report: Endoscopy Simulators. Gastrointestinal Endoscopy. 50(6). 935–937. 12 indexed citations

20.

Nelson, Douglas B., John J. Bosco, Douglas O. Faigel, et al.. (1999). Technology Status Evaluation Report: Biliary Stents. Gastrointestinal Endoscopy. 50(6). 938–942. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact